Health / Biotech
Caribou Biosciences CAR-T Therapy Programs Show Promising Updates
Caribou Biosciences (NASDAQ:CRBU) is making strides in cancer treatment with its innovative allogeneic CAR-T cell therapies. Recent updates highlight the potential of these therapies in treating lymphoma and multiple myeloma, offering new h...